Original article—liver, pancreas, and biliary tractNationwide Increase in Hospitalizations and Hepatitis C Among Inpatients With Cirrhosis and Sequelae of Portal Hypertension
Section snippets
Data Source
All data were extracted from the NIS between 1998 and 2003. It is the largest all-payer database of national hospital discharges, maintained as part of the Healthcare Cost and Utilization Project by the Agency for Healthcare Research and Quality. The NIS is a 20% stratified sample of nonfederal, acute-care hospitals in the United States. This sample includes community and general hospitals and academic medical centers, but excludes long-term facilities. Each record in the NIS represents a
Rates of Hospitalization
The overall rate of hospitalization for cirrhosis complicated by portal hypertension among all individuals in the US census was 23.6 per 100,000 persons annually between 1998 and 2003. Stratified by year, the annual incidence of hospitalization was 21.4 per 100,000 in 1998, 21.7 per 100,000 in 1999, 22.7 per 100,000 in 2000, 23.5 per 100,000 in 2001, 25.4 per 100,000 in 2002, and 26.6 per 100,000 in 2003. On average, there was a statistically significant 5% annual increase in hospitalization
Discussion
In this national study, we found an increase in the estimated incidence of hospitalizations for cirrhosis and complications of portal hypertension in a relatively short 6-year period. We also observed a concurrent increase in the proportion of patients with decompensated cirrhosis with HCV infection. There was a concomitant increase in the total economic burden arising from hospitalizations for complications of portal hypertension that was most pronounced among the subgroup with HCV infection
References (32)
- et al.
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
J Hepatol
(2006) - et al.
Influence of recent advances in medical management on clinical outcomes of cirrhosis
Mayo Clin Proc
(2005) - et al.
Liver and intestine transplantation in the United States, 1995-2004
Am J Transplant
(2006) - et al.
Projecting future complications of chronic hepatitis C in the United States
Liver Transpl
(2003) - et al.
Outcome of hospital care of liver disease associated with hepatitis C in the United States
Hepatology
(2001) - et al.
The APACHE III prognostic systemRisk prediction of hospital mortality for critically ill hospitalized adults
Chest
(1991) - et al.
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
Am J Transplant
(2004) - et al.
Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C
Hepatology
(2000) Alcohol-induced liver disease
Clin Liver Dis
(2000)- et al.
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus
Hepatology
(2002)
A model to predict survival in patients with end-stage liver disease
Hepatology
Deaths: preliminary data for 2004
Natl Vital Stat Rep
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Ann Intern Med
2002 HCUP nationwide inpatient sample (NIS) comparison report
Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies
Pharmacoeconomics
The epidemiology of nonalcoholic fatty liver disease in adults
J Clin Gastroenterol
Cited by (72)
Effects of In-Hospital Rehabilitation on Preventing Hospital Readmissions in Patients With Cirrhosis: A Retrospective Cohort Study
2022, Archives of Physical Medicine and RehabilitationEpidemiological trend of hepatitis C-related liver events in Spain (2000–2015): A nationwide population-based study
2020, European Journal of Internal MedicineThe Health Care Burden of Hepatic Encephalopathy
2020, Clinics in Liver DiseaseCitation Excerpt :The presence of hepatic encephalopathy has been associated with an increase in inpatient length of stay (LOS) among patient with cirrhosis. In a study of the Nationwide Inpatient Sample between 1998 and 2003, patients with hepatic encephalopathy had a 24% longer LOS (95% confidence interval [CI], 22%–26%) compared with cirrhotic patients without hepatic encephalopathy.13 In similar studies using data from the Nationwide Inpatient Sample, the average inpatient LOS was 8.5 days in 2009 and 8.0 days in 2014.10,12
Health Care Utilization and Costs for Patients With End-Stage Liver Disease Are Significantly Higher at the End of Life Compared to Those of Other Decedents
2019, Clinical Gastroenterology and HepatologyCost Effectiveness of Early Insertion of Transjugular Intrahepatic Portosystemic Shunts for Recurrent Ascites
2018, Clinical Gastroenterology and Hepatology
Supported by a Ruth L. Kirschstein individual postdoctoral fellowship grant by the National Institutes of Health (F32DK076257, G.C.N.).